Chronic Hepatitis B Virus Clinical Trials

1 recruiting

Chronic Hepatitis B Virus Trials at a Glance

8 actively recruiting trials for chronic hepatitis b virus are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 1 with 2 trials, with the heaviest enrollment activity in Chengdu, Beijing, and Beijing. Lead sponsors running chronic hepatitis b virus studies include Beijing Friendship Hospital, Bluejay Therapeutics Inc., and Assistance Publique - Hôpitaux de Paris.

Browse chronic hepatitis b virus trials by phase

About Chronic Hepatitis B Virus Clinical Trials

Looking for clinical trials for Chronic Hepatitis B Virus? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chronic Hepatitis B Virus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chronic Hepatitis B Virus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 1

A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection

Chronic Hepatitis B Virus (Hbv)
Jiyan Liu9 enrolled1 locationNCT07051187
Recruiting
Phase 1

A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B

Chronic Hepatitis B Virus Infection
IntegerBio90 enrolled1 locationNCT07389044
Recruiting
Not Applicable

Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation

Chronic Hepatitis B Virus
University Hospital, Limoges140 enrolled3 locationsNCT06853886
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)

Chronic Hepatitis B Virus (HBV) Infection
Brii Biosciences Limited250 enrolled14 locationsNCT06650852
Recruiting

New HBV Infection Biomarkers: Clinical Characterization and Impact on Management

Chronic Hepatitis B Virus (HBV) Infection
Assistance Publique - Hôpitaux de Paris900 enrolled1 locationNCT06906016
Recruiting

Non-Invasive Model for Fibrosis Regression in HBV Patients

Chronic Hepatitis B Virus (HBV) InfectionLiver Fibrosis
Beijing Friendship Hospital1,100 enrolled1 locationNCT06874127
Recruiting
Phase 2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Subjects with Chronic HBV Infection (CHB) and Chronic HDV Infection (CHD).

Chronic Hepatitis D Virus (HDV) InfectionChronic Hepatitis B Virus (HBV) Infection
Bluejay Therapeutics Inc.72 enrolled9 locationsACTRN12623000105640
Recruiting
Phase 4

The Extension Study

Chronic Hepatitis B Virus Infection
Prof. Meng Ngu, Concord Hospital28 enrolled1 locationACTRN12606000283572